Novartis’ rare renal disease candidate shows promise in phase II
Investigational oral treatment is being investigated in C3 glomerulopathy
Read More
Tag: ASN 2020
AZ presents new real-world chronic kidney disease data at ASN 2020
Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed
Read More
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
